The etiology of Alzheimer's disease (AD) is egregiously comprehended, but epidemiological studies have posited that diets rich in the saturated fatty acid palmitic acid (palmitate) are a significant risk factor. The production and accumulation of amyloid beta peptide (Ab) is considered the core pathological molecular event in the pathogenesis of AD. The rate-limiting step in Ab genesis from amyloid-b precursor protein (AbPP) is catalyzed by the enzyme b-site amyloid precursor protein cleaving enzyme 1 (BACE1), the expression and enzymatic activity of which is significantly up-regulated in the AD brain. In this study, we determined the molecular mechanisms that potentially underlie the palmitate-induced up-regulation in BACE1 expression and augmented Ab production. We demonstrate that a palmitate-enriched diet and exogenous palmitate treatment evoke an increase in BACE1 expression and activity leading to enhanced Ab genesis in the mouse brain and SH-SY5Y-APP Swe cells, respectively, through the activation of the transcription factor NF-jB. Chromatin immunoprecipitation (ChIP) assays and luciferase reporter assays revealed that palmitate enhances BACE1 expression by increasing the binding of NF-jB in the BACE1 promoter followed by an enhancement in the transactivation of the BACE1 promoter. Elucidation and delineation of upstream molecular events unveiled a critical role of the endoplasmic reticulum stress-associated transcription factor, C/EBP homologous protein (CHOP) in the palmitateinduced NF-jB activation, as CHOP knock-down cells and Chop À/À mice do not exhibit the same degree of NF-jB activation in response to the palmitate challenge. Our study delineates a novel CHOP-NF-jB signaling pathway that mediates palmitateinduced up-regulation of BACE1 expression and Ab genesis. Abbreviations used: Ab, amyloid beta; AbPP, amyloid beta precursor protein; AD, Alzheimer's disease; BACE1, b-site APP cleaving enzyme 1; ChIP, chromatin immunoprecipitation; CHOP, C/EBP homologous protein; CTFa, carboxy terminal fragment a; CTFb, carboxy terminal fragment b; ER, endoplasmic reticulum; GPR40, G-protein-coupled receptor 40; HIF1a, hypoxia-inducible factor 1-alpha; IKKb, inhibitor of kappa-light-polypeptide gene enhancer of activated B cells, kinase beta; IjBa, inhibitor of nuclear factor of kappa-light-polypeptide gene enhancer of activated B cells, alpha; LDH, lactate dehydrogenase; mTOR, mammalian target of rapamycin; NFT, neurofibrillary tangles; NF-jB, nuclear factor of kappalight-polypeptide gene enhancer of activated B cells; PA, palmitic acid; sAPPa, soluble amyloid beta precursor protein a; sAPPb, soluble amyloid beta precursor protein b; sFFA, saturated free fatty acids.
Alzheimer's disease (AD) is the most common progressive neurodegenerative disorder in the elderly that is characterized by cognitive impairment as well as deficits in learning and memory and is the sixth leading cause of death in the United States. The pathological hallmarks of AD include the intracellular accumulation of aggregated hyperphosphorylated protein tau (s) as neurofibrillary tangles and the extracellular deposition of aggregated amyloid-b (Ab) peptide as neuritic senile plaques. Ab peptide, either in the soluble monomeric and oligomeric form or in the fibrillaraggregated form, is considered a central instigating factor in the pathogenesis of AD (Glenner and Wong 1984; Masters et al. 1985) . The membrane-bound aspartyl protease b-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1, or b-secretase) catalyzes the rate-limiting step in Ab genesis from the transmembrane protein, amyloid-b precursor protein (AbPP), in the amyloidogenic pathway (Hussain et al. 1999; Vassar et al. 1999) . The levels of BACE1 protein as well as its enzymatic activity are significantly augmented in the AD brain (Fukumoto et al. 2002; Holsinger et al. 2002; Yang et al. 2003; Li et al. 2004) . In the amyloidogenic pathway, BACE1 cleaves AbPP at the b-site (Met 671 -Asp 672 ) to generate carboxy terminal fragment b (or C99 fragment), which is subsequently cleaved by the c-secretase complex to generate the Ab peptide (Haass and Selkoe 1993) . Alternatively, in the non-amyloidogenic pathway, a distinct set of enzymes that functionally constitute the group, a-secretases, cleaves AbPP at the a-site (Lys 687 -Leu 688 ) to generate carboxy terminal fragment a (or C83 fragment), which is subsequently cleaved by the c-secretase complex to generate the p3 peptide, thereby precluding the genesis of the deleterious Ab peptide (Haass and Selkoe 1993) . Although the etiology of AD is multifactorial and very poorly comprehended, it is posited that a dynamic interplay among genetic, environmental, and dietary factors plays a role in the etiopathogenesis. Numerous epidemiological studies have suggested that a saturated fat-enriched diet increases risk for AD (Kalmijn et al. 1997; Kalmijn 2000; Morris et al. 2003; Parrott and Greenwood 2007; Barnard et al. 2014) . This has been corroborated and concurred by a multitude of laboratory research studies that have demonstrated that a saturated fat diet causes cognitive impairment as well as deficits in learning and memory in rodent models (Greenwood and Winocur 1990; Winocur and Greenwood 1999) . Saturated fat diets increase the plasma levels of the saturated free fatty acids, palmitic acid (palmitate) and stearic acid (stearate), which cross the blood-brain barrier (Dhopeshwarkar and Mead 1973) and add to the burden of saturated fatty acid pool in the brain (Rapoport 2001; Hamilton and Brunaldi 2007) . Current research and studies from our laboratory have shown that palmitate-enriched diets cause an increase in BACE1 expression, tau phosphorylation and AD-like changes in primary cortical neurons (Patil et al. 2006 (Patil et al. , 2007 Liu et al. 2013a,b) and human SH-SY5Y neuroblastoma cells as well as the mouse hippocampus (Marwarha et al. 2017e) . Our recent studies have also shown that palmitate-induced endoplasmic reticulum (ER) stress (Marwarha et al. 2016) causes an increase in BACE1 expression and activity leading to increases in Ab genesis that is contingent on the activation of C/EBP homologous protein (CHOP) (Marwarha et al. 2017e) . However, the downstream molecular mediators and signaling cascades that lead to a transcriptional increase in BACE1 expression, enhancing BACE1 activity and Ab genesis have not been elucidated yet. In this study, we delineated the mechanisms that are downstream of CHOP and mediate the palmitate-induced increase in BACE1 expression and activity as well as Ab engenderment. ER stress is widely implicated in numerous pathogenic mechanisms that are inherent in AD (Ghribi 2006; Hotamisligil 2010; Marwarha 2011b; Marwarha and Ghribi 2012a; Endres and Reinhardt 2013) . Chronic persistent ER stress results in the increased expression of the transcription factor CHOP (also called growth arrest and DNA damage induced gene-153, GADD153 or DDIT3) (Bartlett et al. 1992; Wang et al. 1996; Zinszner et al. 1998) . In addition to transcriptionally up-regulating the expression of a plethora of genes involved in ER stress response, increased expression of CHOP also enhances the signaling and transcriptional activity of nuclear factor of kappa-light-polypeptide gene enhancer of activated B cells (NF-jB) (Park et al. 2010; Marwarha et al. 2013) . It is well characterized that NF-jB signaling and transcriptional activity positively and directly regulates the transcription of BACE1 (Kaltschmidt et al. 1997; Chen et al. 2012; Marwarha and Ghribi 2017a,b) . Our earlier studies have unveiled a novel CHOP/NF-jB signaling pathway in the regulation of BACE1 expression (Marwarha et al. 2013) . However, the extent to which palmitate modulates these pathways to impinge on BACE1 expression and subsequent Ab genesis is not well known. In this study, we determined the impact of palmitate-enriched diet and exogenous palmitate treatment in the mouse brains and in neuroblastoma cells, respectively, on the dynamics of CHOP/NF-jB signaling interplay and delineated the underlying role of this molecular interplay in the augmentation of BACE1 expression and Ab genesis.
Methods

Materials
Human SH-SY5Y neuroblastoma cells were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA) (Resource Identifier ID -RRID:CVCL_0019). Human SH-SY5Y neuroblastoma cells stably expressing the AbPP Swedish KM670/ 671NL double mutation (SH-SY5Y-APP Swe ) were cultured in Dulbecco's modified Eagle's medium: Ham's F12 with Glutamax (1 : 1; v/v), 10% fetal bovine serum and 1% antibiotic/antimycotic mix. Cells were maintained at 37°C in a saturated humidity atmosphere containing 95% air and 5% CO 2 . All cell culture reagents, with the exception of fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA, USA) and antibiotic/antimycotic mix (Sigma Aldrich, Saint Louis, MO, USA) were purchased from Invitrogen (Carlsbad, CA, USA). Palmitic acid (CAS 57-10-3, Catalog # sc-203175) and sc-514 (CAS 354812-17-2, Catalog # sc-205504) were purchased from Santa Cruz Biotechnology (Dallas, TX, USA). The expression plasmid for over-expressing full length native CHOP (CHOP 6: mCHOP-WT-9E10-pcDNA1) was a gift from Dr. David Ron (Addgene plasmid # 21913). The expression plasmid for over-expressing IjBa (CMV IjB alpha) was a gift from Dr. Inder Verma (Addgene plasmid # 12333). The expression plasmid for ectopically expressing the constitutively dominant active (flag-tagged) inhibitor of kappa-light-polypeptide gene enhancer of activated B cells, kinase beta (IKKb) mutant (IKK2 S177E/S181E) was a gift from Dr. Anjana Rao (Addgene plasmid # 11105) (Mercurio et al. 1997) . The luciferase reporter constructs encoding the NF-jB response elements in the BACE1 promoter region were purchased from SwitchGear Genomics (Active Motif, La Jolla, CA, USA). The human and mouse CHOP double-stranded siRNA (Silencer â Select Pre-Designed & Validated siRNA) and their respective scrambled non-silencing control siRNA were purchased from ThermoFisher Scientific (Waltham, MA, USA). The list of siRNA and their respective targets are enumerated in Table 1 . CHOP shRNA (set of five different shRNA), IKKb shRNA (set of five different shRNA) and IjBa shRNA (set of five different shRNA), all encoded in pLKO.1 lentiviral vector were purchased from Open Biosystems (GE Dharmacon, Lafayette, CO, USA) and their respective target sequences are enumerated in Table 2 .
Cell culture and treatments Transfected SH-SY5Y-APP Swe cells and sc-514 (NF-jB inhibitor) pretreated SH-SY5Y-APP Swe cells (20 lM for 2 h) were treated with different concentrations of bovine serum albumin (BSA)-conjugated palmitate as described previously (Marwarha et al. 2016 . Briefly, palmitate stock solution of 250 mM was prepared in 100% ethanol. BSA (5 mM) stock solution was prepared in MilliQ water (18 MO). Both, the palmitate and BSA stock solutions were sterile filtered using a 0.2-lm filter. The requisite amounts of palmitate and BSA were added to sterile serum-free medium to yield the designated terminal palmitic acid concentrations with the ratio of palmitate and BSA being 6 : 1. The respective media were incubated for 1.5 h to conjugate the palmitic acid to the BSA. The cells were treated with the designated concentration of palmitic acid conjugated to BSA for 24 h.
Mouse experiments
Mice harboring a homozygous targeting deletion mutation to the Ddit3 gene (Chop À/À mice) were procured from The Jackson
(Bar Harbor, ME, USA) (Resource Identifier ID -RRID: IMSR_JAX:005530). The corresponding C57BL/6J control mice were also procured from The Jackson Laboratory (Stock # 000664) (Resource Identifier ID -RRID:IMSR_JAX:000664). The mice were housed in individually ventilated cages at an ambient room temperature (23-25°C) and ambient relative humidity ranging between 50% and 70%. The mice were maintained on 12 : 12 h light : dark cycle and allowed access to food and water ad libitum. Mice were randomly assigned or segregated into the dietary regimen. Chop À/À mice and their wild-type C57BL/6J mice (all males, 9 months of age) counterparts (n = 15), each bearing a definite and exlcusive 'serial number' ascribed for identification purposes during the genotyping phases, were randomly assigned to the given dietary regimen by depicting the individual respective mouse numbers on respective pieces of paper that were collectively pooled, mixed and entered into the drawing 'pot' for assignment into the given dietary cohorts. Two drawing pots containing 30 mice each were generated, each belonging to the respective genotype (Chop À/À mice and their wild-type C57BL/6J mice counterparts).
The respective mouse numbers were drawn from each pot and designated to the respective cohort on an 'alternate assigned' basis, with the odd pickings from the 'pot' (such as the first, third, fifth, seventh and so on so forth) being assigned to the palmitate-enriched diet cohort (TD 110616, Harlan Teklad, 2.2% w/w palmitic acid), while the even pickings from the 'pot' (such as the second, fourth, sixth, eighth and so on so forth) being assigned to the corresponding control diet cohort (TD 85172, Harlan Teklad, 0.8% w/w palmitic acid). The ensuing, randomly generated, four different experimental cohorts of 9-month-old male mice (n = 15 per group) were fed the respective diets for 3 months. The sample size (n = 15) was derived from subjecting data from a pilot experiment to statistical analysis that generated the expected mean and standard deviation. The statistical level of significance (a) was set at 0.05 and the power of the experiment or statistical power (b) was set at 0.8 or 80%. This statistical sampling analysis minimized the number of mice that constituted the experimental cohort. The diets were isocaloric in relation to each other and the respective composition of the diets is shown in Table 3 . Food intake was monitored for the span of 24 h, once every 2 weeks. No changes in food intake were observed (Marwarha et al. 2017e) . Body weights were measured every 2 weeks and reported in our previous study (Marwarha et al. 2017e) . Necropsy was performed at 12 months of age. All animal procedures were carried out in accordance with the US Public Health Service Policy on the Humane Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at the University of North Dakota (Protocol 1506-3c). The study and the research paradigm were not pre-registered and experimental blinding was not used in any of the experimental paradigms and procedures.
Western blot analysis Whole cell, cytosolic and nuclear homogenates from cells as well as the mouse cortices and hippocampi were prepared as previously described (Marwarha et al. 2010a (Marwarha et al. ,b, 2014a . Proteins (10-40 lg) were resolved on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels followed by transfer to a polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA, USA) and incubation with the monoclonal antibodies listed in Table 4 . The origin, source and the dilutions of the respective antibodies used for this study is compiled in Table 4 . b-Actin was used as a gel loading control for whole cell and cytosolic homogenates, whereas histone H3 was used as a gel loading control for nuclear homogenates. The blots were developed with enhanced chemiluminescence (Clarity TM Western enhanced chemiluminescence blotting substrate; Bio-Rad) and imaged using a LiCOR (LiCOR Biotechnology, Lincoln, NE) Odyssey Fc imaging system.
Caspase 3/7 activity assay The enzymatic activities of caspase 3/7 were determined as a surrogate measure of extent of apoptotic activity using the 'CaspaseGlo â 3/7 Assay System' kit from Promega (Catalog # G8090) (Madison, WI, USA) following manufacturer's instructions. Data were normalized to the intensity of the absorbance in BSA-treated cells (control) (set as unit value) and expressed as a fold-change of the control AE SD (six wells per one experiment from three separate experiments, n = 3).
Apoptotic cell death
The effects of CHOP over-expression on apoptotic and necrotic cell death were determined using the 'Annexin V Human ELISA Kit' from ThermoFisher Scientific (Catalog # BMS252) following manufacturer's instructions. Data were normalized to the intensity of the absorbance in BSA-treated empty-vector expressing native cells (set as unit value) and expressed as a fold-change of the control AE SD (six wells per one experiment from three separate experiments, n = 3).
Cell viability assays
The effects of CHOP over-expression on cell proliferation was determined using the 'CyQUANT â Cell Proliferation Assay Kit'
from ThermoFisher Scientific (Catalog # C7026) following manufacturer's instructions. Data were normalized to the intensity of fluorescence in BSA-treated empty-vector expressing native cells (set as unit value) and expressed as a fold-change of the control AE SD (six wells per one experiment from three separate experiments, n = 3).
Lactate dehydrogenase assay for cytotoxicity
The levels of lactate dehydrogenase (LDH) were measured as a surrogate measure of cytotoxic cell death in response to palmitate treatment using the 'CytoTox 96 â Non-Radioactive Cytotoxicity Assay' from Promega (Catalog # G1780) following manufacturer's (14: instructions. Data were normalized to the intensity of the absorbance of maximal LDH release from each respective technical and biological replicate and expressed as percent LDH release relative to maximal LDH release from each respective measurement (six wells per one experiment from three separate experiments, n = 3).
Enzyme-linked immunosorbent assay Ab 1-42 and Ab 1-40 levels in neuroblastoma cells were quantified in the conditioned media (secreted) and cellular homogenates (intracellular) using an ELISA immunoassay kit (Invitrogen) following the manufacturer's protocol and as described earlier (Marwarha et al. 2013 (Marwarha et al. , 2014b . Intracellular Ab 1-42 and Ab 1-40 levels in the cellular homogenates were normalized to total protein content in the samples (pg/mg protein). Treatments were performed in quadruplet (n = 4; four biological replicates with three technical replicates within each biological replicate). The secreted Ab 1-42 and Ab 1-40 levels measured in the culture medium are expressed in pg/ mL of media. Ab 1-42 and Ab 1-40 levels in the mouse hippocampus were quantified using the same aforementioned ELISA immunoassay kit (Invitrogen). The mouse hippocampal tissue was subjected to a sequential extraction procedure (Rostagno and Ghiso 2009) to generate the following subcellular fractions containing the respective Ab species -Tris-buffered saline-soluble Ab (water soluble Ab), 2% SDS soluble Ab (detergent soluble Ab), and 70% formic acid soluble Ab (Tris-buffered saline insoluble Ab, detergent insoluble Ab) that reflects the total Ab pool. Ab levels in the mouse hippocampus were normalized to total protein content in the samples (pg/mg protein).
Quantitative real-time RT-PCR analysis
Total RNA was extracted from treated cells as well as from mouse cortices and hippocampi using the five prime 'PerfectPure RNA tissue kit' (5 Prime, Inc., Gaithersburg, MD, USA) following manufacturer's instructions and as described previously (Marwarha 2011a; Marwarha et al. 2011a Marwarha et al. ,b, 2012 Marwarha et al. , 2014a . cDNA was obtained by reverse transcribing 1 lg of extracted RNA using an 'iScript cDNA synthesis kit' (Bio-Rad). cDNA was obtained by reverse transcribing 1 lg of extracted RNA using an 'iScript cDNA synthesis kit' (Bio-Rad). The quantitative real-time RT-PCR was performed using TaqMan chemistry using 'Assays-on-Demand' probes (ABI, Foster City, CA, USA) for human BACE1 (BACE1 gene) (Hs01121195_m1) and mouse Bace1 (Bace1 gene) (Mm00478664_m1). The amplification was performed using the 'StepOnePlus' PCR System (ABI). The expression of specific transcripts amplified was normalized to the expression of 18s rRNA. Data were quantified and expressed as fold-change compared to the control by using the DDC T method.
FRET-based BACE1 activity assay BACE1 activity in cellular and tissue homogenates was determined using a FRET-based kit from Sigma-Aldrich (Catalog # CS0010) following manufacturer's protocol and as described previously (Marwarha et al. 2009 (Marwarha et al. , 2014b . The raw data expressing the BACE1 activity in terms of percentage of substrate cleaved in respective samples was further normalized and expressed as foldchange compared to control.
Chromatin immunoprecipitation analysis
Chromatin immunoprecipitation (ChIP) analysis was performed to evaluate the extent of p65 binding to the NF-jB binding elements in the BACE1 promoter region using 'SimpleChIP TM Enzymatic Chromatic IP kit' from Cell Signaling (Boston, MA, USA) following manufacturer's instructions and as described earlier (Marwarha et al. 2017a,b,c,e) . The relative abundance of the p65 antibody precipitated chromatin containing the NF-jB binding site in the BACE1 promoter region was determined by qPCR using sequence specific primers (Qiagen Inc. (Valencia, CA, USA) ( Table 5 ). The amplification was performed using the 'StepOnePlus' PCR System (ABI). The fold enrichment of the bound p65 in the BACE1 promoter region was calculated using the DDC T method which normalizes ChIP C T values of each sample to the percentage input and background. Data were further normalized and expressed as fold-change compared to control.
Luciferase reporter assays
Constructs encoding NF-jB response element and human BACE1 promoter conjugated to the firefly luciferase gene were used in the study (Marwarha et al. 2014c) . SH-SY5Y-APP Swe cells were plated in 96-well plates at a density of 2 9 10 4 cells/well. The cells were transfected when 80% confluent with 0.25 lg of reporter constructs.
Respective non-inducible reporter constructs containing constitutively expressing Renilla luciferase were used as negative internal controls. Constitutively expressing GFP constructs were used as positive control to determine transfection efficiency. The dualluciferase assay was performed using a 'Dual-Luciferase Reporter Assay System' (Promega). The luminescence recorded is expressed as Relative Luminescence Units and normalized to per mg protein.
Unit value was assigned to control and the magnitude of differences among the samples is expressed relative to the unit value of control cells.
Statistical analysis
The significance of differences among the samples was assessed by non-parametric Kruskal-Wallis one-way analysis of variance followed by Dunn's post hoc test. Statistical analysis was performed with GraphPad Prism 6. Quantitative data for all the assays are presented as mean values AE SD (mean values AE standard deviation) with unit value assigned to control and the magnitude of differences among the samples being expressed relative to the unit value of control as fold-change. Quantitative data for ELISA analysis are presented as mean values AE SD with absolute concentrations of Ab 1-42 reported. The significance level (a) was set at p < 0.05 establishing a 95% confidence interval (CI) as a threshold of statistical differences among the respective samples.
Results
NF-jB activation and transcriptional activity is required for the palmitate-induced CHOP-mediated increase in BACE1 expression and subsequent engenderment of Ab We determined the effects of palmitate treatment on NF-jB activation in SH-SY5Y-APP Swe human neuroblastoma cells (cells that stably express the Swedish KM670/671NL double mutant AbPP) as well as the effects of palmitateenriched diet on NF-jB activation in the mouse hippocampus. Our recent study showed that exogenous palmitate treatment, for 24 h at 100 lM terminal concentration, increases BACE1 expression in cultured SH-SY5Y-APP Swe cells (Marwarha et al. 2017e) . We therefore used this experimental paradigm, exogenous palmitate at 100 lM terminal concentration in the cell culture medium for 24 h, throughout this study. We determined the levels of phosphorylated IKKb and IjBa in whole cell homogenates as well as the nuclear levels of p65 and p50 following treatment with palmitate, as a surrogate measure of NF-jB activation. Phosphorylation of IKKa/b and IjBa ( Figure S1a and c) as well as the subsequent nuclear translocation of the p65 and p50 subunits of NF-jB was pronouncedly increased in palmitate-treated SH-SY5Y-APP Swe cells (Figure S1b and d) . As NF-jB plays a critical role and directly regulates the transcription of BACE1 (Kaltschmidt et al. 1997) , we next determined the role of NF-jB in palmitateinduced increase in BACE1 expression, augmentation in Ab genesis, and the preferential shunting of AbPP processing toward the amyloidogenic pathway. To this end, we inhibited NF-jB signaling and transcriptional activity by knocking-down IKKb using shRNA or by ectopically overexpressing IjBa in SH-SY5Y-APP Swe cells. We also adopted a chemical approach by using sc-514, an IKKbspecific inhibitor (Baxter et al. 2004) , to abrogate NF-jB signaling and transcriptional activity as shown previously (Marwarha et al. 2013) . Palmitate-evoked increase in BACE1 protein levels (Fig. 1a) , BACE1 mRNA expression and BACE1 activity (Fig. 1b) , as well as amyloidogenic processing of AbPP (Fig. 1a) , in SH-SY5Y-APP Swe cells were significantly reduced with IKKb knock-down, ectopic over-expression of IjBa or pretreatment with sc-514 ( Fig. 1a and b) . Further corroborating the involvement of NF-jB transcriptional activity in the palmitate-induced upregulation of BACE1 expression emanated from ChIP studies demonstrating that palmitate treatment caused an increased in binding of the p65 subunit of NF-jB to the jB-elements in the BACE1 promoter region (Fig. 1c , inset I) as well as an increasing the NF-jB transcriptional activity (Fig. 1c, Inset II) . Furthermore, palmitate treatment also resulted in an increase in BACE1 promoter activity that is contingent on NF-jB transcriptional activity (Fig. 1d) . The palmitate-induced enhancement in the BACE1 promoter activity was significantly mitigated in SH-SY5Y-APP Swe cells with compromised NF-jB activation because of either IKKb knock-down or ectopic over-expression of IjBa or pretreatment with sc-514 (Fig. 1d) , suggesting that NF-jB transcriptional activity is necessary for palmitate-induced increase in BACE1 promoter activity. We next determined intracellular and secreted Ab 1-42 as well as Ab 1-40 as a functional correlate of effects of palmitate mediated through NF-jB activation. Palmitate-induced increase in intracellular as well as secreted Ab 1-42 ( Fig. 2a and b) and Ab 1-40 ( Fig. 2c  and d ) was significantly blunted in SH-SY5Y-APP Swe cells (Wang et al. 2015) with compromised NF-jB activation because of either IKKb knock-down or ectopic over-expression of IjBa or pretreatment with sc-514 ( Fig. 2a-d) , suggesting that NF-jB transcriptional activity is necessary for palmitate-induced increase in Ab genesis ( Fig. 2a-d ).
CHOP expression is necessary for the palmitate-induced increase in NF-jB activation and transcriptional activity We have recently shown that exogenous palmitate treatment and palmitate-enriched diet cause ER stress and induce CHOP expression that leads to an increase in BACE1 expression, enhanced BACE1 activity, and augmentation of Ab genesis in cultured SH-SY5Y-APP Swe cells and the mouse hippocampus, respectively (Marwarha et al. 2017e ). Knocking-down CHOP expression in SH-SY5Y-APP Swe cells significantly attenuates the palmitate-induced increase in BACE1 expression and Ab genesis (Marwarha et al. 2017e) . Furthermore, Chop À/À mice fed a palmitate-enriched diet do not exhibit the same increase in BACE1 expression and Ab burden compared to the C57BL/6J wild-type mice fed a palmitate-enriched diet (Marwarha et al. 2017e ). However, questions still abounded with regard to the molecular mechanism(s) by which CHOP may induce the aforementioned effects. Previous studies from our laboratory (Marwarha et al. 2013 ) and by others (Park et al. 2010; Willy et al. 2015) have cogently also shown that CHOP is required for ER stress-induced activation of NF-jB signaling and transcriptional activity. We next determined the role of CHOP in the palmitate-induced NF-jB-mediated increase in BACE1 expression and Ab genesis. To this end, we determined the palmitate-induced NF-jB activation in a CHOP-deficient paradigm. Palmitate treatment did not evoke the phosphorylation of IKKb and IjBa (Fig. 3a) as well as the subsequent nuclear translocation of the p65 and p50 subunits to the same degree in CHOP knocked-down SH-SY5Y-APP Swe cells compared to the native SH-SY5Y-APP Swe cells (Fig. 3b) . Accordingly, the binding of the p65 subunit of NF-jB to the BACE1 promoter region, as determined by ChIP analysis, was significantly attenuated in palmitate-treated CHOP knocked-down SH-SY5Y-APP Swe cells relative to the palmitate-treated native SH-SY5Y-APP Swe cells (Fig. 3c) . Furthermore, dual-luciferase reporter assays showed a significant reduction in NF-jB driven-BACE1 promoter activity in palmitate-treated CHOP knocked-down SH-SY5Y-APP Swe cells compared to palmitate-treated native SH-SY5Y-APP Swe cells (Fig. 3d) . C57BL/6J wild-type mice fed a palmitate-enriched diet also exhibited pronounced NF-jB activation in the cortex and the hippocampus, as assessed by a significant increase in the phosphorylation of IKKb and IjBa as well as the subsequent nuclear translocation of the p65 and p50 subunits ( Fig. 4a  and b) . However, Chop À/À mice fed a palmitate-enriched diet did not exhibit, to the same degree, the increase in NF-jB activation in the cortex (Fig. 4a ) and the hippocampus (Fig. 4b) as evidenced by a lack in the commensurate increase in the phosphorylation of IKKb and IjBa as well as the subsequent nuclear translocation of the p65 and p50 subunits to the same extent as found in the of C57BL/6J wild-type mice fed a palmitate-enriched diet ( Fig. 4a and b) . Furthermore, the pronounced increase in the binding of the p65 subunit of NF-jB to the BACE1 promoter region, as determined by ChIP analysis, was significantly attenuated in the cortices (Fig. 4c ) and the hippocampi (Fig. 4d) of Chop À/À mice fed a palmitate-enriched diet compared to their C57BL/6J wild-type littermates fed a palmitate-enriched diet ( Fig. 4c and d ). This suggests that the palmitate-induced NF-jB activation and the subsequent increase in BACE1 expression is contingent to a significant degree on CHOP expression.
Palmitate-induced NF-jB activation-mediated increase in BACE1 expression and Ab genesis is downstream of CHOP activation Given that palmitate-induced CHOP and NF-jB activation underlies the mechanism by which palmitate causes an increase in BACE1 expression, BACE1 activity and Ab genesis in SH-SY5Y-APP Swe cells (Figs 1a-d, 2a-d and 3a-d), we next determined whether palmitate-induced upregulation in CHOP expression is upstream or downstream of palmitate-induced augmentation of NF-jB activity in the context of the increase in BACE1 expression. To this end, we first over-expressed CHOP in SH-SY5Y-APP Swe cells with compromised activation of NF-jB achieved with IKKb knock-down or ectopic over-expression of IjBa. We found that CHOP over-expression resulted in an increase in basal as well as palmitate-induced augmentation of BACE1 protein levels (Fig. 5a ), BACE1 mRNA expression (Fig. 5c ) and BACE1 activity (Fig. 5d) , amyloidogenic processing of AbPP (Fig. 4a) , intracellular as well as secreted Ab 1-42 ( Fig. 6a and b) and Ab 1-40 levels ( Fig. 6c and d) . However, CHOP over-expression in cells devoid of NF-jB-transcriptional activity, as a result of IKKb knock-down or by ectopic over-expression of IjBa, caused no significant increase in BACE1 protein levels (Fig. 5a ), BACE1 mRNA expression (Fig. 5c ) and BACE1 activity (Fig. 5d) , amyloidogenic processing of AbPP (Fig. 5a ), intracellular as well as secreted Ab 1-42 ( Fig. 6a and b) and Ab 1-40 levels ( Fig. 6c  and d) , irrespective of the ectopic CHOP over-expression ( Fig. 4a-f ). This demonstrated that NF-jB signaling is both necessary for and downstream of ER stress-induced CHOP expression in the palmitate-induced up-regulation of BACE1 expression ( Fig. 5a-d ) and Ab genesis (Fig. 6a-d) . We further extricated underlying cell death as a potential confounding factor in the effects observed in ectopic CHOP over-expressing cells, as an increase in CHOP expression and transcriptional activity is known to induce cell death (Zinszner et al. 1998 ). We did not observe any underlying changes in caspase 3/7 activity, apoptotic and necrotic cell death, as well as cell proliferation in the CHOP overexpressing cells ( Figure S2a-d) . CHOP over-expression did not result in any changes in the enzymatic activity of the effector caspases 3/7, both in the control-treated as well as palmitate-treated cells ( Figure S2a ). We also determined the extent of annexin V bound to phosphatidylserine-exposing apoptotic cells as a surrogate marker of early apoptotic cell death (Koopman et al. 1994; Vermes et al. 1995) . There were no changes in the abundance of Annexin V conjugates suggesting no early apoptotic events, in both the control-treated as well as palmitate-treated cells CHOP over-expressing cells ( Figure S2b ). To further extricate any apoptotic or necrotic mediated cell death, we determined the extent of LDH release and accumulation in the conditioned medium of all experimental groups. We observed no significant changes in LDH release and accumulation in CHOP over-expressing cells ( Figure S2c) . Furthermore, there were no changes in cell proliferation as a consequence of CHOP over-expression ( Figure S2d) , thereby extricating underlying cell proliferation fluxes in the effects elicited by CHOP over-expression. Our data is in accordance with other studies that have unveiled a very intricate temporal kinetic profile of CHOP-induced cell death, suggesting that only chronic CHOP activation induces apoptotic cell death, but not acute CHOP activation (McCullough et al. 2001; Han et al. 2013) .
We also performed the corollary experiment, which entailed knocking-down CHOP expression in SH-SY5Y-APP Swe while constitutively activating NF-jB signaling and transcriptional activity by ectopically expressing the dominant active IKKb (IKKb S177E) mutant or knocking-down IjB (Figs 7a-d and 8a-d) . This resulted in a pronounced increase in basal as well as palmitate-induced augmentation of BACE1 protein levels (Fig. 7a) , BACE1 mRNA expression (Fig. 7c ) and BACE1 activity (Fig. 7d) , amyloidogenic processing of AbPP (Fig. 7a) , intracellular as well as secreted Ab (Fig. 8a and b) and Ab 1-40 levels ( Fig. 8c  and d) , despite the knock-down of CHOP, corroborating that NF-jB signaling is indeed downstream of ER stress-induced CHOP expression and consequently a more proximal regulator of BACE1 expression (Fig. 7a-d) and Ab genesis (Fig. 8a-d) than CHOP.
Discussion
Diets rich in saturated fats are widely implicated in cognitive disorders including dementia of the Alzheimer's type and mild cognitive impairment (MCI) (Barnard et al. 2014) . Numerous epidemiological studies have posited that saturated fat-enriched diets increase the risk of developing AD (Kalmijn et al. 1997; Kalmijn 2000; Morris et al. 2003; Parrott and Greenwood 2007; Barnard et al. 2014) . A plethora of laboratory studies have also shown that a diet rich in saturated fat causes cognitive dysfunction as well as deficits in learning and memory in different murine models of cognitive function assessment (Greenwood and Winocur 1990; Winocur and Greenwood 1999) . While there is extensive epidemiological evidence implicating saturated fat and palmitate-enriched diets in precipitating cognitive impairment, evoking deficits in learning and memory, the underlying molecular determinants that mediate the effects, especially in the etiopathogenesis of AD are poorly characterized. Palmitate has been shown to increase de novo ceramide synthesis and expression of pro-inflammatory cytokines in primary astrocytes in culture that led to an increase in BACE1 expression in primary cortical neurons that were challenged with the conditioned medium from the palmitate-treated primary astrocytes (Patil et al. 2006 (Patil et al. , 2007 Liu et al. 2013a,b; Liu and Chan 2014) . A wide spectrum of laboratory studies have demonstrated the effects of a high-fat diet on BACE1 activity and Ab burden in a multitude of rodent models of AD (Refolo et al. 2000; Levin-Allerhand et al. 2002; Ho et al. 2004; Cao et al. 2007; Thirumangalakudi et al. 2008; Fitz et al. 2010; Julien et al. 2010; Maesako et al. 2012 Maesako et al. , 2015 Wang et al. 2013; Vandal et al. 
2014
). In these studies, the dietary composition varied significantly pertaining to the content of saturated fatty acids, mono-and polyunsaturated fatty acids, as well as total lipids. Moreover, many studies utilized a dietary regimen that entailed the presence of high cholesterol (Refolo et al. 2000; Levin-Allerhand et al. 2002; Thirumangalakudi et al. 2008; Fitz et al. 2010; Wang et al. 2013 ) and high sucrose (Cao et al. 2007 ) concomitant with high fat in the context of the macromolecular composition. Furthermore, the respective diets did not exhibit parity in caloric density, another confounding determinant as high caloric diets are associated with increased risk of AD (Luchsinger et al. 2002) . Highcholesterol diets have been shown to induce AD-like pathology (Sparks et al. 1994; Refolo et al. 2000; Shie et al. 2002; Puglielli et al. 2003; Ghribi 2008; Ghribi and Marwarha 2010) as well as being associated with the pathogenesis of other diseases (Marwarha et al. 2017d) . Therefore, the inference drawn from the aforementioned studies, in the context of enhanced Ab burden in the brain as a consequence of diet, cannot exclusively be ascribed to the saturated fat content, but also to the presence of other macromolecular variables that make-up the constitution of the respective diet. A recent study demonstrated that treatment with exogenous palmitate increases Ab levels in SK-N-MC neuroblastoma cells by activating the G-proteincoupled receptor 40/Akt/mammalian target of rapamycin/ HIF1a and the G-protein-coupled receptor 40/Akt/NF-jB signaling pathways (Kim et al. 2017) . However, no in vivo study to date has characterized the effects of a palmitateenriched diet per se on the transcriptional regulation of BACE1 expression and Ab genesis and characterized the mechanisms. This current study is the first to demonstrate the effects of a palmitate-enriched diet, per se, on the upstream signaling mechanisms and transcription factors that dictate BACE1 expression. We recently implicated ER stressinduced enhanced expression of CHOP in the palmitateenriched diet and exogenous palmitate treatment-induced increase in BACE1 activity and Ab engenderment (Ghribi fed a palmitate-enriched diet (3 months) compared to the age-matched C57BL/6J wild-type mice fed a palmitateenriched diet (Marwarha et al. 2017e) . Furthermore, the palmitate-enriched diet-induced increase in total BACE1 activity in the cortex and hippocampi of C57BL/6J wild-type mice was significantly blunted in the Chop À/À mice fed a palmitate-enriched diet (Marwarha et al. 2017e) .
In this study we demonstrate that NF-jB activation mediates the palmitate-induced increase in BACE1 expression and activity that leads to enhanced Ab genesis. We further demonstrate that the palmitate-induced CHOP activation-mediated enhanced BACE1 expression and the palmitate-induced NF-jB activation-mediated enhanced BACE1 expression are not two independent, disparate molecular events. Instead, the two are part of the same linear signaling pathway evoked by palmitate, and that ER stress-induced CHOP activation by palmitate is upstream of palmitate-induced NF-jB activation. The role of NF-jB in the neurodegenerative mechanism involved in the etiopathogenesis of AD have been the substrate of numerous studies and reviews (Mattson and Meffert 2006; Srinivasan and Lahiri 2015; Snow and Albensi 2016; Marwarha and Ghribi 2017a,c) . Multiple lines of evidence have demonstrated increased NF-jB signaling and transcriptional activity in the AD brain (Boissiere et al. 1997; Kaltschmidt et al. 1997) . Saturated fat-enriched diets resulting in higher levels of saturated free fatty acids, palmitate and stearate, in the plasma are known to cause increase NF-jB activation in peripheral tissues (Kennedy et al. 2009; Van Beek et al. 2012; Estadella et al. 2013) . In this study, we demonstrate that palmitate-enriched diet evokes NF-jB activation in the mouse hippocampus and subsequently increases the NF-jB-mediated transactivation of the BACE1 promoter. We further show that the inhibition of NF-jB signaling and transcriptional activity significantly attenuates the palmitate-induced augmentation in BACE1 expression and Ab genesis in cultured human SH-SY5Y neuroblastoma cells. The transcriptional regulation of BACE1 by NF-jB transcriptional activity has been very well characterized (Bourne et al. 2007; Buggia-Prevot et al. 2008; Marwarha 2011a; Chen et al. 2012; Ghribi 2012b, 2017b; Marwarha et al. 2013 Marwarha et al. , 2014b . There is also extensive evidence that NF-jB signaling and transcriptional activity regulates Ab production either through the regulation of BACE1 activity or independent of BACE1 activity (Tomita et al. 2000; Paris et al. 2007; Pandey et al. 2009; Chami et al. 2012; Kim et al. 2017) . A few studies have shown that NF-jB transcriptional activity represses BACE1 promoter activity and BACE1 expression (Bourne et al. 2007 ). This duality in BACE1 promoter modulation by NF-jB could be attributed to the molecular composition of the NF-jB heterodimer. BACE1 promoter is transactivated by the p65/p50 and p65/p52 NF-jB heterodimers, while the binding of c-Rel/p52 NF-jB heterodimers transrepresses the BACE1 promoter (Bourne et al. 2007 ). Our study is the first to demonstrate that a palmitate-enriched diet increases BACE1 expression and Ab burden in the mouse hippocampus by increasing NF-jB-mediated transactivation of the BACE1 promoter. We further show that this palmitate-induced NF-jB transctivation of the BACE1 promoter is significantly contingent on palmitate-induced CHOP expression which is upstream of NF-jB activation. Future studies delving into the molecular entities and mediators that link the activation of CHOP to NF-jB activation are being designed and tested by our group. Furthermore, the involvement of palmitate-induced NF-jB activation in the pathogenesis of other neurodegenerative disorders needs to be explored as well (Marwarha and Ghribi 2015) . The effects of exogenous palmitate treatment in cells and palmitate-enriched diet on c-secretase activity or on the expression of individual respective components of the csecretase complex were not determined in this study. It is conceivable that palmitate-induced increase in Ab genesis could be a composite of both, increase BACE1 enzymatic activity as well as c-secretase enzymatic activity. This study focused on the palmitate-induced transcriptional up-regulation of BACE1 and unveiled a novel palmitate-induced cross-talk between CHOP and NF-jB signaling that underlies BACE1 regulation at the transcriptional level. Our study delineates and elucidates a novel signaling cascade, CHOP/ NF-jB signaling pathway in mediating the palmitate-induced up-regulation in BACE1 expression and Ab genesis. Further studies are warranted to determine the role of this pathway in the palmitate-induced cognitive impairment as well as learning and memory deficits. It is known that BACE1 apportionment into different subcellular compartments is the primary determinant of Ab genesis (Cole and Vassar 2007; Zhang and Song 2013) . Our current studies are determining the effects of palmitate on BACE1 levels and specific BACE1 enzymatic activity in different cellular fractions -endoplasmic reticulum (ER) membrane, trans Golgi network, endosomes and plasma membrane. Furthermore, BACE1 is localized into distinct subcellular microdomains within neurons, primarily in the dendrites and the axons (Laird et al. 2005; Goldsbury et al. 2006 ) and undergoes unidirectional endosomal-mediated anterograde transport, concomitant with AbPP, along the axonal axis toward the presynaptic terminals (Laird et al. 2005; Goldsbury et al. 2006; Zhao et al. 2007; Thinakaran and Koo 2008; Sannerud et al. 2011) . It is largely the consensus, the neuronal Ab is engendered within this endocytic compartment during the anterograde transport along the axonal axis (Lazarov et al. 2002; Sheng et al. 2002; Cirrito et al. 2005; Harris et al. 2010; Sokolow et al. 2012) . Characterizing this axonal pool of BACE1 is of seminal relevance in AD, as an increase in BACE1 accumulation is observed in the brains of AD patients as well as brains of 5xFAD and Tg2576 mice (Zhao et al. 2007; Kandalepas et al. 2013) . Our future studies are aimed at determining and dissecting the effects of palmitate on this endocytic compartmentalization and axonal trafficking of BACE1. BACE1 is extensively localized in the presynaptic terminals (Zhao et al. 2007) where it plays an indispensable role in synaptic transmission impinging on physiological and behavioral correlates of learning and memory as well as cognitive function (Yan and Vassar 2014) . Current ongoing studies by our group are determining the effects of palmitateenriched diets on surrogate correlates of behavior as well as cognitive function and substantiating the putative role of CHOP/NF-jB signaling cross-talk elicited fluxes in BACE1 targeting that could underlie the behavioral and cognitive deficits evoked by palmitate-enriched diets.
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